Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence

Autor: Shuya Yano, Michael Bouvet, Kiyoto Takehara, Shinji Miwa, Robert M. Hoffman, Shunsuke Kagawa, Yasuo Urata, Hiroshi Tazawa, Toshiyoshi Fujiwara, Hiroyuki Kishimoto
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Telomerase
Gene Expression
Triple Negative Breast Neoplasms
Complete resection
Metastasis
Green fluorescent protein
Mice
Computer-Assisted
0302 clinical medicine
Recurrence
Transduction
Genetic

Triple-negative breast cancer
Cells
Cultured

Microscopy
Cultured
Tumor
Optical Imaging
adenovirus
nude mice
3. Good health
Oncology
Surgery
Computer-Assisted

030220 oncology & carcinogenesis
Female
fluorescence-guided surgery
Research Paper
medicine.medical_specialty
Cells
Oncology and Carcinogenesis
Genetic Vectors
Green Fluorescent Proteins
survival
Fluorescence
triple negative
Cell Line
Adenoviridae
Transduction
03 medical and health sciences
breast cancer
Breast cancer
Genetic
Cell Line
Tumor

medicine
Animals
Humans
orthotopic
Animal
business.industry
Cancer
GFP/RFP
medicine.disease
Xenograft Model Antitumor Assays
Surgery
Disease Models
Animal

030104 developmental biology
Microscopy
Fluorescence

Disease Models
Cancer cell
business
fluorescence-guided surgery (FGS)
telomerase dependent
Zdroj: Oncotarget
Oncotarget, vol 7, iss 46
ISSN: 1949-2553
Popis: // Shuya Yano 1, 2, 3 , Kiyoto Takehara 1, 2, 3 , Shinji Miwa 1, 2 , Hiroyuki Kishimoto 3 , Hiroshi Tazawa 4 , Yasuo Urata 5 , Shunsuke Kagawa 3 , Michael Bouvet 2 , Toshiyoshi Fujiwara 3 , Robert M. Hoffman 1, 2 1 AntiCancer, Inc., San Diego, CA, USA 2 Department of Surgery, University of California San Diego, CA, USA 3 Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan 4 Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan 5 Oncolys BioPharm Inc., Tokyo, Japan Correspondence to: Robert M. Hoffman, email: all@anticancer.com Toshiyoshi Fujiwara, email: toshi_ f@md.okayama-u.ac.jp Keywords: fluorescence-guided surgery (FGS), telomerase dependent, adenovirus, GFP/RFP, survival Received: July 07, 2016 Accepted: September 06, 2016 Published: September 28, 2016 ABSTRACT We have previously developed a genetically-engineered GFP-expressing telomerase-dependent adenovirus, OBP-401, which can selectively illuminate cancer cells. In the present report, we demonstrate that targeting a triple-negative high-invasive human breast cancer, orthotopically-growing in nude mice, with OBP-401 enables curative fluorescence-guided surgery (FGS). OBP-401 enabled complete resection and prevented local recurrence and greatly inhibited lymph-node metastasis due to the ability of the virus to selectively label and subsequently kill cancer cells. In contrast, residual breast cancer cells become more aggressive after bright (white)-light surgery (BLS). OBP-401-based FGS also improved the overall survival compared with conventional BLS. Thus, metastasis from a highly-aggressive triple-negative breast cancer can be prevented by FGS in a clinically-relevant mouse model.
Databáze: OpenAIRE